OTC · Financial Statements
G Medical Innovations Holdings Ltd (GMVDF) Financial Statements
$0.00
OTC: GMVDF
Market Cap $25992
Overview Financials Dividend
G Medical Innovations Holdings Ltd most recently reported annual revenue of $4.0M, a net loss of $25.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022
Revenue $2.0M $4.0M $5.0M $5.0M $4.0M Operating Profit $-13.0M $-9.0M $-12.0M $-11.0M $-22.0M Net Profit $-13.0M $-11.0M $-13.0M $-15.0M $-25.0M EPS $-6.77 $-4.92 $-59.67 $-45.49 $-34.17 Op Margin -561.2% -231.3% -251.0% -221.1% -500.3%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022
Total Assets $11.0M $6.0M $5.0M $11.0M $5.0M Total Liabilities $13.0M $13.0M $8.0M $13.0M $9.0M Cash $3.0M $1.0M $0 $6.0M $0 Borrowings $9.0M $10.0M $3.0M $8.0M $2.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022
Operating Cash Flow $-12.0M $-6.0M $-5.0M $-11.0M $-18.0M Investing Cash Flow $-6.0M $-1.0M $-1.0M $-1.0M $-4.0M Financing Cash Flow $0 $0 $0 $0 $2.0M Net Cash Flow $-9.0M $-3.0M $0 $6.0M $-6.0M Free Cash Flow $-14.0M $-7.0M $-5.0M $-12.0M $-21.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.21 FCF Yield -79255.16% Quick Ratio 0.19 Interest Coverage -5.42 Return 1Y 0.00% Return 3Y -99.96% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .